Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
Chen-yong Lin
Journal of Biological Chemistry, 2008
View PDFchevron_right
The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor
Chen-yong Lin
Journal of Biological Chemistry, 2003
View PDFchevron_right
The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
Hsiang-po Huang
Scientific reports, 2017
View PDFchevron_right
Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease
Chen-yong Lin
Journal of Biological Chemistry, 2000
View PDFchevron_right
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters
Chen-yong Lin
Clinical cancer research : an official journal of the American Association for Cancer Research, 2002
View PDFchevron_right
The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma
Michela Palmieri
Cancer, 2003
View PDFchevron_right
Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist
H. Maun
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein
sean hunter
The Journal of biological chemistry, 2018
View PDFchevron_right
Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids
Pierre-Luc Boudreault
European Journal of Medicinal Chemistry, 2017
View PDFchevron_right
Design and Synthesis of Potent, Selective Inhibitors of Matriptase
Eric Marsault, Richard Leduc
ACS Medicinal Chemistry Letters, 2012
View PDFchevron_right
Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells
Tohru Fushiki
Cytotechnology, 2009
View PDFchevron_right
Crystal Structures of Matriptase in Complex with Its Inhibitor Hepatocyte Growth Factor Activator Inhibitor-1
Dan qu
Journal of Biological Chemistry, 2013
View PDFchevron_right
Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells
Chen-yong Lin
AJP: Cell Physiology, 2011
View PDFchevron_right
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers
Timothy Hoey
Biochemical Journal, 2005
View PDFchevron_right
Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients
Robert Mansel
Clinical Cancer Research, 2007
View PDFchevron_right
Human Cancer Cells Retain Modest Levels of Enzymatically Active Matriptase Only in Extracellular Milieu following Induction of Zymogen Activation
Chen-yong Lin
PLoS ONE, 2014
View PDFchevron_right
A Novel Biomarker for Staging Human Prostate Adenocarcinoma: Overexpression of Matriptase with Concomitant Loss of its Inhibitor, Hepatocyte Growth Factor Activator Inhibitor-1
Hasan Mukhtar
Cancer Epidemiology Biomarkers & Prevention, 2006
View PDFchevron_right
Matriptase and HAI1 Are Expressed by Normal and Malignant Epithelial Cells in Vitro and in Vivo
Baljit Singh
American Journal of Pathology, 2001
View PDFchevron_right
Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity
Chen-yong Lin
Journal of Biological Chemistry, 1999
View PDFchevron_right
Inhibitors of proteases as anticancer drugs
Andrej Jedinák
Neoplasma
View PDFchevron_right
Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors
Silvia Wein
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Identification of the Matriptase Second CUB Domain as the Secondary Site for Interaction with Hepatocyte Growth Factor Activator Inhibitor Type-1
Tohru Fushiki
Journal of Biological Chemistry, 2010
View PDFchevron_right
Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase
Pablo Fuentes-Prior
Journal of Biological Chemistry, 2001
View PDFchevron_right
Addition of 1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin
Eiji Miyoshi
Glycobiology, 2003
View PDFchevron_right
Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA
juliano ALVES
Biochemical Journal, 2010
View PDFchevron_right
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
Troy Messick
Oncotarget, 2016
View PDFchevron_right
Protein Expression of Matriptase and its Cognate Inhibitor HAI-1 in Human Prostate Cancer
Chen-yong Lin
Applied Immunohistochemistry & Molecular Morphology, 2009
View PDFchevron_right
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease
Chen-yong Lin
American Journal of Physiology-Cell Physiology, 2005
View PDFchevron_right
Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies
Torsten Steinmetzer
International Journal of Cancer, 2010
View PDFchevron_right
Hepatocyte Growth Factor Activator Inhibitor, a Novel Kunitz-type Serine Protease Inhibitor
Kimitoshi Denda
Journal of Biological Chemistry, 1997
View PDFchevron_right
Proteases and Protease Inhibitors: Implications in Antitumorigenesis and Drug Development
Nitin Patil
2007
View PDFchevron_right
α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer
Mohammad Shohib
ChemMedChem, 2016
View PDFchevron_right